The RAS/RAF/MEK/extracellular-signal-regulated kinase (ERK) MAPK and the PI3K/AKT pathways are frequently dysregulated in various human cancers as a result of genetic alterations in their components or upstream activation of cell-surface receptors [1]. Here, AKT1 is linked to cancer.